PTC Therapeutics Inc (NASDAQ:PTCT)

29.96
Delayed Data
As of May 22
 -0.56 / -1.83%
Today’s Change
12.15
Today|||52-Week Range
33.22
+79.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues25.2M36.8M82.7M194.4M
 
 
 
 
 
Cost of Goods Sold------2.3M
 
 
Depreciation And Amortization2.2M2.9M3.3M17.7M
 
 
 
 
 
 
Operating ExpensesGross Income------174.4M
 
 
General Expenses122.4M201.0M209.0M238.7M
 
 
 
 
 
Research And Development79.8M121.8M117.6M117.5M
 
 
 
 
 
Total Operating Expenses124.7M203.9M212.3M258.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-99.4M-167.1M-129.6M-64.3M
 
 
 
 
 
Extraordinary Credit0.00140.0K47.0K0.00
 
 
 
Extraordinary Charge-130.0K0.00-2.5M0.00
 
 
 
Interest Expense On Debt0.002.4M8.3M12.1M
 
 
 
 
Other Expenses-83.0K-605.0K-1.3M-1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-98.4M-170.0M-141.5M-77.7M
 
 
 
 
 
Income Taxes-4.7M-485.0K-569.0K-1.3M
 
 
 
 
 
Net Income-93.8M-170.4M-142.1M-79.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.6M33.6M34.0M39.2M
 
 
 
 
 
Shares To Calculate EPS Diluted31.6M33.6M34.0M39.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.97-$5.07-$4.17-$2.02
 
 
 
 
 
EPS Diluted-$2.97-$5.07-$4.17-$2.02